From Name

From Email

To Name

To Email

Message

Assessing safety of aspirin in high-risk patients with atherosclerotic cardiovascular disease

from Clinical Advisor

Assessing safety of aspirin in high-risk patients with atherosclerotic cardiovascular disease Clinical Advisor The use of aspirin as a primary prevention for atherosclerotic cardiovascular disease (ASCVD) in high-risk patients has been controversial. Aspirin is known to lower the risk of heart attack and stroke, but it also may increase the risk of major bleeding episodes. In a new study, researchers have found no evidence that the use of aspirin for higher-risk primary prevention is beneficial. The study was published in The American Journal of Medicine. READ MORE

more